The legacy of Viagra and its originator, copyright, presents a fascinating picture for prospective investors. While the blockbuster drug initially fueled enormous profits , its patent has ended, leading to rival options flooding the market . This erosion in value presents a significant hurdle for copyright and any portfolio considering a significan